X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
92
PharmaCompass offers a list of Flurazepam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flurazepam manufacturer or Flurazepam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flurazepam manufacturer or Flurazepam supplier.
PharmaCompass also assists you with knowing the Flurazepam API Price utilized in the formulation of products. Flurazepam API Price is not always fixed or binding as the Flurazepam Price is obtained through a variety of data sources. The Flurazepam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Flurazepam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flurazepam, including repackagers and relabelers. The FDA regulates Flurazepam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flurazepam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flurazepam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flurazepam supplier is an individual or a company that provides Flurazepam active pharmaceutical ingredient (API) or Flurazepam finished formulations upon request. The Flurazepam suppliers may include Flurazepam API manufacturers, exporters, distributors and traders.
click here to find a list of Flurazepam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Flurazepam DMF (Drug Master File) is a document detailing the whole manufacturing process of Flurazepam active pharmaceutical ingredient (API) in detail. Different forms of Flurazepam DMFs exist exist since differing nations have different regulations, such as Flurazepam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Flurazepam DMF submitted to regulatory agencies in the US is known as a USDMF. Flurazepam USDMF includes data on Flurazepam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Flurazepam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Flurazepam suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Flurazepam Drug Master File in Japan (Flurazepam JDMF) empowers Flurazepam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Flurazepam JDMF during the approval evaluation for pharmaceutical products. At the time of Flurazepam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Flurazepam suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Flurazepam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Flurazepam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Flurazepam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Flurazepam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Flurazepam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Flurazepam suppliers with NDC on PharmaCompass.
Flurazepam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flurazepam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flurazepam GMP manufacturer or Flurazepam GMP API supplier for your needs.
A Flurazepam CoA (Certificate of Analysis) is a formal document that attests to Flurazepam's compliance with Flurazepam specifications and serves as a tool for batch-level quality control.
Flurazepam CoA mostly includes findings from lab analyses of a specific batch. For each Flurazepam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flurazepam may be tested according to a variety of international standards, such as European Pharmacopoeia (Flurazepam EP), Flurazepam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flurazepam USP).
Market Place
